These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1194 related articles for article (PubMed ID: 29728993)
1. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993 [TBL] [Abstract][Full Text] [Related]
2. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiota, hypertension and chronic kidney disease: Recent advances. Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in chronic kidney disease. Cigarran Guldris S; González Parra E; Cases Amenós A Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986 [TBL] [Abstract][Full Text] [Related]
6. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids. Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376 [TBL] [Abstract][Full Text] [Related]
7. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine]. Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? Cavalcanti Neto MP; Aquino JS; Romão da Silva LF; de Oliveira Silva R; Guimarães KSL; de Oliveira Y; de Souza EL; Magnani M; Vidal H; de Brito Alves JL Pharmacol Res; 2018 Apr; 130():152-163. PubMed ID: 29410236 [TBL] [Abstract][Full Text] [Related]
9. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease. Li F; Wang M; Wang J; Li R; Zhang Y Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in kidney disease and hypertension. Antza C; Stabouli S; Kotsis V Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in chronic kidney disease: challenges and opportunities. Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743 [TBL] [Abstract][Full Text] [Related]
12. The Role of the Gut Microbiome on Chronic Kidney Disease. Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581 [TBL] [Abstract][Full Text] [Related]
13. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
14. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Meijers B; Jouret F; Evenepoel P Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498 [TBL] [Abstract][Full Text] [Related]
15. The clinical impact of gut microbiota in chronic kidney disease. Kim SM; Song IH Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729 [TBL] [Abstract][Full Text] [Related]
16. Microbiota issue in CKD: how promising are gut-targeted approaches? Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677 [TBL] [Abstract][Full Text] [Related]
17. Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature. Feng Z; Wang T; Dong S; Jiang H; Zhang J; Raza HK; Lei G J Int Med Res; 2021 Oct; 49(10):3000605211053276. PubMed ID: 34704483 [TBL] [Abstract][Full Text] [Related]
18. The impact of gut microbiota on kidney function and pathogenesis. Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798 [TBL] [Abstract][Full Text] [Related]
19. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311 [TBL] [Abstract][Full Text] [Related]
20. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Briskey D; Tucker P; Johnson DW; Coombes JS Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]